Literature DB >> 11883124

Study of anticardiolipin antibodies in repeated abortions--an institutional experience.

J J Sheth1, F J Sheth.   

Abstract

A cohort of 178 pregnant women with a history of first or second trimester abortions (2 or more) were the base of present study. In all, other causes of abortion were ruled out except for anti-phospholipid syndrome. Anti-Cardiolipin antibody (ACA) (IgG & IgM) was estimated in the sera samples of all women. Out of 178 women, any one or both immunoglobulins were above the cut off range (> 15.0 units) in 47 (26.4%) while both immunoglobulins were normal in 131 (73.59%) women. Both immunoglobulins were present in only 0.5% women. ACA-IgG alone was present in 11.79% while ACA-IgM alone was present in 14.04% women. We observe from present study that ACA is a major cause of recurrent fetal loss & many pregnancies can be saved if diagnosed & treated adequately.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11883124

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  3 in total

1.  Incidence of anticardiolipin antibodies and lupus anticoagulant factor among women experiencing unexplained recurrent abortion and intrauterine fetal death.

Authors:  Noura Al Jameil; Poonam Tyagi; Amal Al Shenefy
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

2.  Study on antiphospholipid/anticardioliplin antibodies in women with recurrent abortion.

Authors:  Farideh Akhlaghi; Mohamad Reza Keramati; Mehri Tafazoli
Journal:  Iran Red Crescent Med J       Date:  2013-08-05       Impact factor: 0.611

3.  Antiphospholipid antibodies among pregnant women with recurrent fetal wastage in a tertiary hospital in Northern Nigeria.

Authors:  Zubaida Garba Abdullahi; Mohammmed A Abdul; Sirajo M Aminu; Bolanle O P Musa; Lawal Amadu; El-Bashir M Jibril
Journal:  Ann Afr Med       Date:  2016 Jul-Sep
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.